PD23-04: Delayed Survival Benefit of Enzalutamide Plus Radium-223 in Metastatic Castration-Resistant Prostate Cancer: A Reconstructed Individual Patient Data Analysis of the PEACE-3 Trial
Sunday, May 17, 2026 3:54 PM to 4:02 PM · 8 min. (America/New_York)
206
Abstract